Sort
30,917 grants matching “tumor microenvironment”
Dissecting the role of hypoxia in T cell differentiation in cancer
$614,462Greg M. Delgoffe · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
Therapeutic Targeting Mitochondrial C1 Metabolism
$614,438Larry H. Matherly · Wayne State University · R01 · FY2025 · CA
Molecular Pathology of Cancer
$614,275Michael R Emmert-Buck · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA
Mouse models of Kras-mutant colorectal cancer
$614,235Kevin Michael Haigis · Dana-Farber Cancer Inst · R01 · FY2022 · CA
BASE TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMAKERSTASK ORDER TITLE: VACCINES AGAINS
$614,163Margie Clapper · Research Inst Of Fox Chase Can Ctr · N01 · FY2022 · CA
Innovative mRNA vaccines to enhance the efficacy of T-cell transfer therapies against solid tumors
$614,124Caius Gabriel Radu · University Of California Los Angeles · R01 · FY2025 · CA
Metabolic impact on T cell-mediated cancer immunity and therapy
$614,115Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
Role of Eya3 in regulating the immune microenvironment to promote breast tumor progression
$614,111Heide L Ford · University Of Colorado Denver · R01 · FY2017 · CA
Role of inflammation in epigenetic alterations of metastatic cancer cells
$614,078Li Yang · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Targeting LIF/LIFR in pancreatic cancer
$614,006Hareesh Babu Nair · Evestra, Inc. · R44 · FY2020 · CA
Novel immunological biomarkers ovarian cancer prognosis
$613,871Brahm H. Segal · Roswell Park Cancer Institute Corp · R01 · FY2019 · CA
Adoptive T Cell Therapy for Pancreatic Cancer
$613,867Cassian Yee · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Immune Impact on Cancer Chemoresistance
$613,838Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2021 · CA
Immune Impact on Cancer Chemoresistance
$613,838Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2020 · CA
Deciphering Mechanisms by which Tumor Cells Collaborate to Mediate Metastasis
$613,781Heide L Ford · University Of Colorado Denver · R01 · FY2021 · CA
Novel Hyperpolarized MR Markers of Advanced Prostate Cancer Therapy
$613,774John Kurhanewicz · University Of California, San Francisco · R01 · FY2012 · CA
Patient-specific, high-sensitivity spectral CT for assessment of pancreatic cancer
$613,764Peter B Noãl · University Of Pennsylvania · R01 · FY2022 · EB
Naive T cells in Cancer Immune Evasion and Immunotherapy
$613,750Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2017 · CA
In Vivo Production of CAR-Microglia for Treating Alzheimerâs Disease
$613,571Jun Huang · University Of Chicago · R61 · FY2025 · AG
Glycomics Laboratory for the Development of Ovarian Cancer Biomarkers
$613,410Karen L. Abbott · Florida International University · U01 · FY2022 · CA
Studies of Human T Regulatory Cells
$613,363Ethan Shevach · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Development of First-in-Class RIPK1 Degraders to Improve Cancer Immunotherapies
$613,358Jin Wang · Baylor College Of Medicine · R01 · FY2024 · CA
Role of IKK alpha in lung cancer development
$613,256Yinling Hu · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Engineering Native E. coli to Detect, Report, and Treat Colorectal Cancer
$613,187Amir Zarrinpar · University Of California, San Diego · U01 · FY2023 · CA
MOLECULAR DISSECTION OF SEIZURE MICROENVIRONMENT IN MALIGNANT GLIOMA
$613,164Jeffrey Noebels · Baylor College Of Medicine · R01 · FY2019 · CA